Online forum on clinical application advances of Co-Ablation System: the second session

Online forum on clinical application advances of Co-Ablation System: the first session

Minimally invasive oncology is an active topic in international frontier medicine, and "MADE IN CHINA" has become a key member of the global toolbox.

From August 6th to August 11th, 2022, hosted by Chinese Medical Association Beijing Branch Secretariat, Beijing Medical Association Respiratory Endoscopy and Interventional Branch, “ The 9th Beijing Respiratory Endoscopy and Interventional Respiratory Medicine Summit Forum, The 7th Beijing-Tianjin-Hebei Interventional Pulmonology Symposium and the 16th Peking University International Interventional Pulmonology Technical Training Course” were held in Beijing. The national experts in the field of interventional pulmonology gathered to share new progress, new theories, new technologies and new application in the field.

Recently, the Ministry of Industry and Information Technology of the People's Republic of China announced the list of the fourth batch of National-Level Specialized, Special and New "Little Giant" enterprises.

There is such a company. The founder of the company, Huang Qianfu, and his team have spent more than ten years grinding "a probe"-Co-Ablation System, a cryosurgery system for minimally invasive tumor treatment.

On the morning of July 8, 2022, Ren Yiding, deputy secretary of the Youth League Committee of Haidian District, and other leaders came to Hygea Medical to conduct the flag handing over ceremony of the youth volunteer service team and the awarding ceremony of the Haidian District Youth Model Unit Award.

Hygea Medical Technology Co., Ltd. was once again selected as one of FUTURE HEALTHCARE VB100

The Hygea Medical Youth League Committee organized the youth league members to learn from General Secretary Xi Jinping's speech at the celebration of the 100th anniversary of the founding of the Communist Youth League of China.

The China-Japan Friendship Hospital's General Surgery and Thyroid and Breast Surgery is conducting a "Non-randomized controlled clinical study of Co-Ablation System cryoablation and breast-conserving surgery in the treatment of early-stage low-risk breast cancer". This study has been approved by the Ethics Committee of the China-Japan Friendship Hospital. Volunteers who volunteered to participate in the study are now being recruited.